Fundraising FoxDermata Therapeutics
NASDAQ: DRMASan Diego, US · Founded 2021 · Delaware corporation
Find your way into Dermata Therapeutics
Sign up to see every warm intro you have to Dermata Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dermata Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dermata develops and distributes direct-to-consumer skincare products based on dermatologic science, offering topical treatments intended to simplify consumers' skincare routines. Its initial planned launch is a once-weekly skin renewal kit, with additional products to follow.
Founders & leadership
MB
Maria Bedoya Toro MuneraExecutive
KK
Kyri K. Van HooseExecutive
CJ
Christopher J. NardoExecutive
TI
Tom InsleyChief Financial Officer
GT
Gerald T. ProehlPresident, Chief Executive Officer and Chairman
Board
BB
Brittany BradrickBoard director
MF
Mary FisherBoard director
KS
Kathleen ScottBoard director
SM
Steven MentoBoard director
WW
Wendell WierengaBoard director
AS
Andrew SandlerBoard director
DH
David HaleBoard director
Reported raises · per SEC filings
Form D private placements$32.1M disclosed across 9 of 13 rounds · 1900–2025
▶$4.1MraisedJan 2026 · 14 investors · BiotechnologyRule 506(b)
▶$4.1MraisedJan 2026 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maria Bedoya Toro MuneraExecutive Officer
- Mary FisherDirector
- Kathleen ScottDirector
- Steven MentoDirector
- Wendell WierengaDirector
- Gerald ProehlExecutive Officer, Director
- Andrew SandlerDirector
- Kyri K. Van HooseExecutive Officer
- David HaleDirector
- Christopher J. NardoExecutive Officer
- Brittany BradrickDirector
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- Sales commissions
- $342.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MraisedFeb 2025 · 8 investors · Other TechnologyRule 506(b)
▶$2.5MraisedFeb 2025 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald ProehlExecutive Officer, Director
- Brittany BradrickDirector
- Christopher J. NardoExecutive Officer
- Maria Bedoya Toro MuneraExecutive Officer
- Steven MentoDirector
- Mary FisherDirector
- Kathleen ScottDirector
- Kyri K. Van HooseExecutive Officer
- Wendell WierengaDirector
- Andrew SandlerDirector
- David HaleDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Sales commissions
- $174.8K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.5MraisedSep 2024 · 1 investors · Other TechnologyRule 506(b)
▶$3.5MraisedSep 2024 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MentoDirector
- Gerald ProehlExecutive Officer, Director
- Andrew SandlerDirector
- Wendell WierengaDirector
- Kathleen ScottDirector
- Kyri K. Van HooseExecutive Officer
- Brittany BradrickDirector
- David HaleDirector
- Maria Bedoya Toro MuneraExecutive Officer
- Mary FisherDirector
- Christopher J. NardoExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Sales commissions
- $345K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶Undisclosed amountofferedJun 2023 · 2 investors · Other TechnologyRule 506(b)
▶Undisclosed amountofferedJun 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kyri K. Van HooseExecutive Officer
- Kathleen ScottDirector
- Mary FisherDirector
- David HaleDirector
- Christopher J. NardoExecutive Officer
- Wendell WierengaDirector
- Maria Bedoya Toro MuneraExecutive Officer
- Steven MentoDirector
- Brittany BradrickDirector
- Andrew SandlerDirector
- Gerald T. ProehlDirector, Executive Officer
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3MraisedDec 2020 · 37 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2020 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hale BioPharma Ventures, LLCPromoter, Executive Officer
- David F. HaleExecutive Officer, Director, Promoter
- Wendell WierengaDirector
- Tom InsleyExecutive Officer
- Chris NardoExecutive Officer
- Gerald T. ProehlDirector, Promoter, Executive Officer
- Amount sold
- $3M
- First sale
- Jul 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5MraisedMay 2018 · 49 investors · BiotechnologyRule 506(b)
▶$5MraisedMay 2018 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris NardoExecutive Officer
- David F. HaleExecutive Officer, Director, Promoter
- Gerald T. ProehlDirector, Promoter, Executive Officer
- Tom InsleyExecutive Officer
- Hale BioPharma Ventures, LLCPromoter, Executive Officer
- Amount sold
- $5M
- First sale
- Nov 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$6.9MraisedMay 2018 · 49 investors · BiotechnologyRule 506(b)
▶$6.9MraisedMay 2018 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David F. HaleExecutive Officer, Director, Promoter
- Chris NardoExecutive Officer
- Gerald T. ProehlDirector, Promoter, Executive Officer
- Tom InsleyExecutive Officer
- Hale BioPharma Ventures, LLCPromoter, Executive Officer
- Amount sold
- $6.9M
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$651.3KraisedJun 2015 · 7 investors · BiotechnologyRule 506(b)
▶$651.3KraisedJun 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David F. HaleExecutive Officer, Director, Promoter
- Chris NardoExecutive Officer
- Hale BioPharma Ventures, LLCPromoter, Executive Officer
- Tom InsleyExecutive Officer
- Gerald T. ProehlDirector, Promoter
- Amount sold
- $651.3K
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Dermata Therapeutics do?
- Dermata develops and distributes direct-to-consumer skincare products based on dermatologic science, offering topical treatments intended to simplify consumers' skincare routines. Its initial planned launch is a once-weekly skin renewal kit, with additional products to follow.
- How much funding has Dermata Therapeutics raised?
- Dermata Therapeutics has disclosed $32.1M raised across 9 of its 13 known rounds.
- Where is Dermata Therapeutics headquartered?
- Dermata Therapeutics is headquartered in San Diego, US.